{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP02104",
    "Peptide Name": "Warnericin RK (natural AMPs; bacteriocin; hemolysins; Gram-positive bacteria, prokaryotes; BBMm)",
    "Source": "Staphylococcus warneriRK",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "MQFITDLIKKAVDFFKGLFGNK",
    "Sequence Length": 22,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram-",
      "Hemolytic"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 2,
    "Boman Index": 0.57,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "50%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Activity: When tested at 50 ug/ml, active against Gram+ B. megaterium F04, Gram- L. bozemanii ATCC 33217, L. dumofii ATCC 33279, L. feeleii ATCC 35072, L. like bacteria, L. longbeachae ATCC 33484, L. micdadei ATCC 33218, L. oakridgensis ATCC 33761, L. pneumophila Corby (sg1), L. pneumophila Lens (sg1), L. pneumophila Paris (sg1), L. pneumophila ATCC 33155 (sg3), L. pneumophila ATCC 33216 (sg5), and L. pneumophila ATCC 33215 (sg6).  In addition, MIC assays: L. pneumophila Lens (MIC 3 ug/ml) and B. megaterium (MIC 12 ug/ml). Its anti-Legionella activity is modulated by fatty acid composition. Cells in stationary phase, which were already described as less resistant than cells in exponential phase, displayed higher amounts of branched-chain fatty acids (BCFA) and short chain fatty acids (Verdon J, et al. 2011).Toxicity: : highly hemolytic (hRBC HC50 3.12 uM).  Updated 8/2017; 7/2021",
    "Author": "Verdon J, Berjeaud JM, Lacombe C, HÃ©chard Y.2008",
    "Reference": "Peptides. 2008 Jun;29(6):978-84.Pub-Med.",
    "Title": "Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri."
  },
  "3D Structure": []
}